| Bharat Immunological & Biological Corporation Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524663 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE994B01014 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : -7.54 |
Market Cap(₹Cr) : 89.17 |
Face Value(₹) : 10.00 |
| Particulars | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 44.61 | 78.39 | 85.33 | 66.84 | 83.65 |
| Other Income | 2.80 | 1.10 | 1.68 | 1.18 | 4.22 |
| Stock Adjustments | -5.95 | -0.44 | -20.15 | 12.99 | 13.55 |
| Total Income | 41.46 | 79.05 | 66.86 | 81.01 | 101.42 |
| EXPENDITURE : | |||||
| Raw Materials | 35.71 | 64.93 | 67.74 | 74.30 | 92.79 |
| Power and Fuel Cost | 1.35 | 1.69 | 1.55 | 1.85 | 1.74 |
| Other Manufacturing Expenses | 1.16 | 1.39 | 1.22 | 1.53 | 1.17 |
| Selling and Administration Expenses | 1.05 | 0.73 | 0.60 | 0.65 | 0.45 |
| Miscellaneous Expenses | 2.53 | 0.33 | 0.49 | 0.53 | 0.59 |
| Employee Benefit Expenses | 15.32 | 13.85 | 14.44 | 11.37 | 9.78 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | -15.66 | -3.87 | -19.18 | -9.22 | -5.10 |
| Interest | 7.05 | 5.60 | 4.79 | 4.75 | 2.00 |
| Gross Profit | -22.71 | -9.47 | -23.97 | -13.97 | -7.10 |
| Depreciation | 0.15 | 0.21 | 0.24 | 0.24 | 0.28 |
| Profit Before Tax | -22.86 | -9.68 | -24.21 | -14.21 | -7.38 |
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -5.79 | -0.93 | -6.10 | -3.99 | -1.58 |
| Reported Net Profit | -17.06 | -8.75 | -18.11 | -10.21 | -5.79 |
| Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Net Profit | -17.06 | -8.75 | -18.11 | -10.21 | -5.79 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.01 | -1.02 |
| Profit/Loss Balance carried down | -49.57 | -40.82 | -22.71 | -12.50 | -5.69 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -66.63 | -49.57 | -40.82 | -22.71 | -12.50 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | -3.95 | -2.03 | -4.19 | -2.36 | -1.34 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | -5.43 | -1.48 | 0.55 | 4.74 | 7.10 |
| Book Value(Adj)-Unit Curr | -5.43 | -1.48 | 0.55 | 4.74 | 7.10 |